SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-17-007185
Filing Date
2017-07-05
Accepted
2017-07-05 17:53:34
Documents
53
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_nexusbiopharma.htm 10-K 597144
2 CERTIFICATION f10k2017ex31i_nexusbiopharma.htm EX-31.1 16505
3 CERTIFICATION f10k2017ex32i_nexusbiopharma.htm EX-32.1 6283
10 GRAPHIC img_001.jpg GRAPHIC 27867
11 GRAPHIC img_002.jpg GRAPHIC 82685
12 GRAPHIC img_003.jpg GRAPHIC 153843
13 GRAPHIC img_004.jpg GRAPHIC 90288
14 GRAPHIC img_005.jpg GRAPHIC 100385
15 GRAPHIC img_006.jpg GRAPHIC 69984
16 GRAPHIC img_007.jpg GRAPHIC 59231
17 GRAPHIC img_008.jpg GRAPHIC 54658
18 GRAPHIC img_009.jpg GRAPHIC 139901
  Complete submission text file 0001213900-17-007185.txt   3172723

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nexs-20170228.xml EX-101.INS 234854
5 XBRL SCHEMA FILE nexs-20170228.xsd EX-101.SCH 26464
6 XBRL CALCULATION FILE nexs-20170228_cal.xml EX-101.CAL 20226
7 XBRL DEFINITION FILE nexs-20170228_def.xml EX-101.DEF 56865
8 XBRL LABEL FILE nexs-20170228_lab.xml EX-101.LAB 210007
9 XBRL PRESENTATION FILE nexs-20170228_pre.xml EX-101.PRE 139100
Mailing Address 8 HILLSIDE AVE STE 108 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVE STE 108 MONTCLAIR NJ 07042 832-758-7488
NEXUS BIOPHARMA INC (Filer) CIK: 0001424151 (see all company filings)

IRS No.: 753267338 | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-53207 | Film No.: 17949239
SIC: 2834 Pharmaceutical Preparations